{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Gastroesophageal Reflux Disease: 2021 Guideline Updates and Clinical Pearls

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the pathophysiology and symptoms of GERD.
  2. Recognize the appropriate diagnostic process based on patient-specific factors.
  3. Summarize pharmacologic and nonpharmacologic GERD management.

Learning Outcomes

Seventy-five percent of participants will be able to demonstrate competency in clinical reasoning for gastroesophageal reflux disease (GERD) based on the 2021 American College of Gastroenterology (ACG) clinical guideline updates and clinical pearls by achieving a posttest score of 70% or greater.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 0.5 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Awarded Advanced Pharmacology Hours













Test Code: NP0723A
Published: Jul 2023
Expires: 6/5/2026
Required Passing Score: 7/10 (70%)
Authors: Whitney Smith, DNP, APRN, PCAGNP-BC; Natalia Davila, DNP, APRN, CPNP